Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 3, 2023. (Total: 223614Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Drug-Induced Liver Injury and meta-analysis and NAT2[original query]
Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008 Sep 12 (9): 994-1002.
Sun F, Chen Y, Xiang Y, Zhan
NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2012 May 16 (5): 589-95.
Wang P-Y, Xie S-Y, Hao Q, Zhang C, Jiang B
Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.
PloS one 2012 7 (10): 10.
Cai Y, Yi J, Zhou C, Shen X
Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.
Pharmacogenomics 2015 Nov .
Shi Jing, Xie Min, Wang Jianmiao, Xu Yongjian, Liu Xianshe
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis.
British journal of clinical pharmacology 2018 Jul .
Zhang Min, Wang Shuqiang, Wilffert Bob, Tong Rongsheng, van Soolingen Dick, van den Hof Susan, Alffenaar Jan-Will
NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
Pharmacogenetics and genomics 2018 Jul 28 (7): 167-176.
Suvichapanich Supharat, Fukunaga Koya, Zahroh Hilyatuz, Mushiroda Taisei, Mahasirimongkol Surakameth, Toyo-Oka Licht, Chaikledkaew Usa, Jittikoon Jiraphun, Yuliwulandari Rika, Yanai Hideki, Wattanapokayakit Sukanya, Tokunaga Katsus
Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
BMJ open 2019 Aug 9 (8): e027940.
Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens. GWAS Catalog
Clinical pharmacology and therapeutics 2020 11 109 (4): 1125-1135.
Nicoletti Paola, Devarbhavi Harshad, Goel Ashish, Venkatesan Radha, Eapen Chundamannil E, Grove Jane I, Zafer Samreen, Bjornsson Einar, Lucena M Isabel, Andrade Raul J, Pirmohamed Munir, Wadelius Mia, Larrey Dominique, Maitland-van der Zee Anke-Hilse, Ibanez Luisa, Watkins Paul B, Daly Ann K, Aithal Guruprasad
TOP